Identification of a novel heparin-binding site in the alternatively spliced IIICS region of fibronectin: roles of integrins and proteoglycans in cell adhesion to fibronectin splice variants - PubMed (original) (raw)
Identification of a novel heparin-binding site in the alternatively spliced IIICS region of fibronectin: roles of integrins and proteoglycans in cell adhesion to fibronectin splice variants
Z Mostafavi-Pour et al. Matrix Biol. 2001 Feb.
Abstract
The extracellular matrix molecule fibronectin (FN) is a glycoprotein whose major functional property is to support cell adhesion. FN contains at least two distinct cell-binding domains: the central cell-binding domain and the HepII/IIICS region. The HepII region comprises type III repeats 12-14 and contains proteoglycan-binding sites, while the alternatively spliced IIICS segment possesses the major alpha4beta1 integrin-binding sites. Both cell surface proteoglycans and integrins are important for mediating the adhesion of cells to this region of FN. By comparing heparin binding to different recombinant splice variants of the HepII/IIICS region, evidence was obtained for the existence of a novel heparin-binding site in the centre of the IIICS. Site-directed mutagenesis of basic amino acid sequences in this region reduced heparin binding to recombinant HepII/IIICS proteins and, in conjunction with mutations in the HepII region, caused a synergistic loss of activity. Using the H/120 variant of FN, which contains type III repeats 12-15 and the full-length IIICS region, and the H/95 variant of FN, which contains type III repeats 12-15 but lacks the high affinity integrin-binding LDV sequence, the relative roles played by cell-surface proteoglycans and integrins in mediating cell adhesion have been investigated. This was achieved by studying the effects of anti-integrin antibodies and exogenous heparin on A375 melanoma cell attachment to the wild-type and three different mutants of H/120 and H/95 in which the potential proteoglycan-binding sites were partially or completely removed. A375 cell adhesion to H/120 and its mutants was found to involve the co-operative action of both integrin and cell-surface proteoglycan binding, although integrin made a dominant contribution. Anti-integrin antibodies and exogenous heparin were capable of inhibiting melanoma cell adhesion to H/95 and in this case adhesion was due primarily to cell-surface proteoglycan and not integrin binding.
Similar articles
- Fibronectin and integrins in invasion and metastasis.
Akiyama SK, Olden K, Yamada KM. Akiyama SK, et al. Cancer Metastasis Rev. 1995 Sep;14(3):173-89. doi: 10.1007/BF00690290. Cancer Metastasis Rev. 1995. PMID: 8548867 Review. - Mechanisms of VCAM-1 and fibronectin binding to integrin alpha 4 beta 1: implications for integrin function and rational drug design.
Humphries MJ, Sheridan J, Mould AP, Newham P. Humphries MJ, et al. Ciba Found Symp. 1995;189:177-91; discussion 191-9. doi: 10.1002/9780470514719.ch13. Ciba Found Symp. 1995. PMID: 7587632 Review.
Cited by
- Serum fibronectin levels in malignant and benign endometrial diseases.
Mitev D, Slavov S, Dimitrov G, Shikova I, Hristova J, Kostov S, Yordanov A. Mitev D, et al. Prz Menopauzalny. 2024 Sep;23(3):140-144. doi: 10.5114/pm.2024.143419. Epub 2024 Oct 14. Prz Menopauzalny. 2024. PMID: 39464496 Free PMC article. - Fibronectin: Molecular Structure, Fibrillar Structure and Mechanochemical Signaling.
Dalton CJ, Lemmon CA. Dalton CJ, et al. Cells. 2021 Sep 16;10(9):2443. doi: 10.3390/cells10092443. Cells. 2021. PMID: 34572092 Free PMC article. Review. - Shaping Up the Tumor Microenvironment With Cellular Fibronectin.
Efthymiou G, Saint A, Ruff M, Rekad Z, Ciais D, Van Obberghen-Schilling E. Efthymiou G, et al. Front Oncol. 2020 Apr 30;10:641. doi: 10.3389/fonc.2020.00641. eCollection 2020. Front Oncol. 2020. PMID: 32426283 Free PMC article. Review. - Comparative Proteomic Profiling and Biomarker Identification of Traditional Chinese Medicine-Based HIV/AIDS Syndromes.
Wen L, Liu YF, Jiang C, Zeng SQ, Su Y, Wu WJ, Liu XY, Wang J, Liu Y, Su C, Li BX, Feng QS. Wen L, et al. Sci Rep. 2018 Mar 8;8(1):4187. doi: 10.1038/s41598-018-22611-3. Sci Rep. 2018. PMID: 29520099 Free PMC article. Clinical Trial. - The fibronectin ED-A domain enhances recruitment of latent TGF-β-binding protein-1 to the fibroblast matrix.
Klingberg F, Chau G, Walraven M, Boo S, Koehler A, Chow ML, Olsen AL, Im M, Lodyga M, Wells RG, White ES, Hinz B. Klingberg F, et al. J Cell Sci. 2018 Mar 1;131(5):jcs201293. doi: 10.1242/jcs.201293. J Cell Sci. 2018. PMID: 29361522 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous